Core for COVID-19 Cohort (IMPACC)
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3U19AI089992-09S1
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$1,087,629Funder
National Institutes of Health (NIH)Principal Investigator
DAVID A HAFLERResearch Location
United States of AmericaLead Research Institution
YALE UNIVERSITYResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
A core facility for the IMPACC study group will be formed to conduct analyses of samplescollected by the individual study sites. Shared protocols for subject enrollment and samplecollection have been established by the IMPACC study group. Collection and shipping to thecore site will be overseen by the Data Coordinating Center. Core assays will includemultiparameter single cell CyTOF of endotracheal aspirates and DNA sequencing. Corefunctions will be conducted in close collaboration with the IMPACC study group and includesample tracking and management, design of antibody labeling panel, sample processing andacquisition, DNA sequencing, initial data quality analysis and data sharing.